AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE667.202.05 (+0.31 %)
PREV CLOSE ( ) 665.15
OPEN PRICE ( ) 672.20
BID PRICE (QTY) 667.20 (122)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 141314
TODAY'S LOW / HIGH ( )664.90 676.75
52 WK LOW / HIGH ( )504 808.95
NSE667.602.25 (+0.34 %)
PREV CLOSE( ) 665.35
OPEN PRICE ( ) 675.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 667.60 (177)
VOLUME 1303384
TODAY'S LOW / HIGH( ) 665.65 676.90
52 WK LOW / HIGH ( )503.05 809.45
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
27Nov Aurobindo Pharma eyeing inorganic grow
Aurobindo Pharma is looking at inorganic growth opportunities in Eastern..
27Nov Aurobindo Pharma surges on eyeing inor
Aurobindo Pharma is currently trading at Rs. 721.60, up by 7.05 points o..
22Nov Aurobindo Pharma informs about schedul
Aurobindo Pharma has informed about the schedule of Investors/Analysts c..
18Nov Aurobindo Pharma informs about company
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
16Nov Aurobindo Pharma informs about investo
Aurobindo Pharma has informed that the Company is participating in inves..
Financials
Rs. in Millions
QTR Sep 17 ANNUAL 17
Net Profit7528.317067.6
Gross Profit 9664.4 21785.7
Operating Profit 10680.725099
Net Sales 30738.697812.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2372.00 (2.52%)
M.Cap (Rs. in Cr)39348.46
Merck (BSE)
 1211.35 (2.65%)
M.Cap (Rs. in Cr)2010.77
Torrent Pharma (BSE)
 1342.95 (2.13%)
M.Cap (Rs. in Cr)22725.77
Zandu Realty (BSE)
 1994.40 (1.39%)
M.Cap (Rs. in Cr)160.83
Pfizer (BSE)
 1995.70 (1.17%)
M.Cap (Rs. in Cr)9129.87
Shareholding Pattern
PROMOTERS 51.87%
MUTUAL FUNDS/UTI 14.89%
NON-INSTITUTION 13.98%
FI/BANKS/INSURANCE 0.46%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.